Southeast Asia's only nuclear power plant, completed four decades ago in Bataan, about 40 miles from the Philippine capital ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP ...

In December, Astra and Daiichi withdrew an application in the EU for the drug to treat a type of lung cancer after feedback from regulatory advisers. Mixed results from a late-stage trial showed ...

Daiichi Sankyo’s board of directors followed the nomination committee’s report in making the appointment. Credit: ArDanMe/Shutterstock. Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed ...

NEW YORK – AstraZeneca and Daiichi Sankyo have begun treating high-risk non-small cell lung cancer patients with their TROP2-directed antibody drug conjugate Datroway (datopotamab deruxtecan) and ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

which still lingers at fission reactors like the Fukushima Daiichi plant that melted down in 2011. "A fusion device must achieve stable operation at high efficiency for thousands of seconds to enable ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

President Trump canceled the security clearance of the 51 Spies Who Lied. Photo by JIM WATSON/AFP via Getty Images President Trump was darn right to revoke the security clearance of the 51 Spies ...

Creator Dan Erickson explains the reason why Helly chose to lie about her outie. Helly's deceit adds tension to the storyline as her true motivations remain mysterious to both her colleagues and ...

However, the asset faced a series of setbacks in 2024. The FDA on Friday approved AstraZeneca and Daiichi Sankyo’s Dato-DXd, to be known as Datroway, for patients with certain advanced breast ...